Spain· ES:57150
EULITOP RETARD 400 mg COMPRIMIDOS DE LIBERACION PROLONGADA
A medicinal product containing bezafibrato, registered in Spain by Aurovitas Spain, S.A.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- bezafibrato
- Manufacturer
- Aurovitas Spain, S.A.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo97140830EUR 8.57
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bezafibrato in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBezafibrate 400mg modified-release tabletsWaymade Healthcare Plc
- NetherlandsBezalip Retard 400 mg, tabletten met gereguleerde afgifteEuro Registratie Collectief B.V.
- FinlandBezafibrat GenericsGenerics (UK) Limited
- NorwayBezalip RetardAurobindo Pharma
- CanadaBEZALIP SRALLERGAN INC
- SwedenBezalip Retard 400 mg DepottablettActavis Group PTC ehf.
- FranceBEFIZAL L.P. 400 mg, comprimé enrobé à libération prolongéeARROW GENERIQUES
- BelgiumEulitop 400 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 14 EEA countries. Names it is sold under:
- Austria · Bezalip Retard, Bezastad
- Belgium · Cedur, Eulitop
- Cyprus · Lacromid, Zafibral
- Germany · Bezafibrat Al, Bezafibrat Retard Al
- Finland · Bezalip
- France · Befizal, Befizal L.P.
- United Kingdom (Northern Ireland) · Bezafibrate, Bezafibrate Noumed Life Sciences
- Hungary · Bezalip
- Italy · Bezalip
- Luxembourg · Cedur, Eulitop
- Netherlands · Bezafibrate Aurobindo
- Portugal · Bezalip, Bezalip Retard
- Romania · Bezafibrat Arena
- Sweden · Bezalip, Bezalip Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fdefbef9-f9a4-42de-8f6f-b7d3f518b887 GET /v1/drugs/fdefbef9-f9a4-42de-8f6f-b7d3f518b887?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":528505200000}",
"nregistro": "57150",
"substance": "bezafibrato"
}See everything about bezafibrato.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.